Neurophysiological endophenotypes across bipolar and schizophrenia psychosis

Schizophrenia Bulletin

Volumn 34, Issue 4, 2008, Pages 760-773

  Thaker, Gunvant K ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Bipolar disorder; Endophenotype; Gamma band; Genes; Mismatch negativity; Schizophrenia; Sensory gating P 300; Smooth pursuit eye movements

Indexed keywords

ALPHA 7 NICOTINE RECEPTOR; CATECHOL METHYLTRANSFERASE; HALOPERIDOL; KETAMINE; NEU DIFFERENTIATION FACTOR; NICOTINE; NICOTINIC RECEPTOR; PROTEIN P300; PROTEIN P50;

BIPOLAR I DISORDER; DYSLEXIA; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; EYE MOVEMENT; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; SENSORIMOTOR INTEGRATION; SMOOTH PURSUIT EYE MOVEMENT;

ACOUSTIC STIMULATION; BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FAMILY; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; OCULAR MOTILITY DISORDERS; PHENOTYPE; SACCADES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 46849100660     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn049     Document Type: Review

References (170)

1. Morel BA. Traité des Degenerescences Physiques, Intellectuelles et Morales de l'espece Humaine. Paris Masson; 1857.
2. Kraepelin E. Dementia Praecox and Paraphrenia. New York, NY: RE Krieger; 1919.
3. Kendler KS, Gardner CO. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol Med. 1997;27(2):411-419.
4. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187-1192.
5. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123(1):48-58.
6. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry. 2002;159(4):539-545.
7. Gottesman, II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry. 1973;122(566):15-30.
8. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636-645.
9. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002;3(8):617-628.
10. Tsuang MT, Faraone SV, Lyons MJ. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci. 1993;243(3-4):131-142.
11. Leonard S, Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry. 2006;60(2):115-122.
12. Schwarzkopf SB, Lamberti JS, Smith DA. Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry. 1993;33(11-12):815-828.
13. Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study. Biol Psychiatry. 1999;45(7):883-890.
14. Louchart-de la Chapelle S, Nkam I, Houy E, et al. A concordance study of three electrophysiological measures in schizophrenia. Am J Psychiatry. 2005;162(3):466-474.
15. Ettinger U, Hejda S, Flak V, Corr PJ. Prepulse inhibition of the acoustic startle reflex and oculomotor control. Psychophysiology. 2005;42(4):473-482.
16. Hong LE, Summerfelt A, Adami HM, et al. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. Am J Psychiatry. 2007;164(1):61-65.
17. Orban d X, Lefevre P. Saccades and pursuit: two outcomes of a single sensorimotor process. J Physiol. 2007;584(Pt 1):11-23.
18. Thier P, Ilg UJ. The neural basis of smooth-pursuit eye movements. Curr Opin Neurobiol. 2005;15(6):645-652.
19. Avila MT, Hong LE, Moates A, Turano KA, Thaker GK. Role of anticipation in schizophrenia-related pursuit initiation deficits. J Neurophysiol. 2006;95(2):593-601.
20. Hong LE, Tagamets M, Avila M, et al. Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study. Biol Psychiatry. 2005;57(7):726-732.
21. Blohm G, Missal M, Lefevre P. Interaction between smooth anticipation and saccades during ocular orientation in darkness. J Neurophysiol. 2003;89(3):1423-1433.
22. Blohm G, Missal M, Lefevre P. Direct evidence for a position input to the smooth pursuit system. J Neurophysiol. 2005;94(1):712-721.
23. Holzman PS. Eye movements and the search for the essence of schizophrenia. Brain Res Brain Res Rev. 2000;31(2-3):350-356.
24. Calkins ME, Iacono WG. Eye movement dysfunction in schizophrenia: a heritable characteristic for enhancing phenotype definition. Am J Med Genet. 2000;97(1):72-76.
25. Levy DL, Holzman PS, Matthysse S, Mendell NR. Eye tracking and schizophrenia: a selective review. Schizophr Bull. 1994;20(1):47-62.
26. Diefendorf AR, Dodge R. An experimental study of the ocular reactions of the insane from photographic records. Brain. 1908;31:451-489.
27. Holzman PS, Proctor LR, Hughes DW. Eye-tracking patterns in schizophrenia. Science. 1973;181(95):179-181.
28. Holzman PS, Levy DL, Proctor LR. Smooth pursuit eye movements, attention, and schizophrenia. Arch Gen Psychiatry. 1976;33(12):1415-1420.
29. Amador XF, Malaspina D, Sackeim HA, et al. Visual fixation and smooth pursuit eye movement abnormalities in patients with schizophrenia and their relatives. J Neuropsychiatry Clin Neurosci. 1995;7(2):197-206.
30. Blackwood DH, Sharp CW, Walker MT, et al. Implications of comorbidity for genetic studies of bipolar disorder: P300 and eye tracking as biological markers for illness. Br J Psychiatry. 1996;30:Suppl85-92.
31. Boudet C, Denise P, Bocca ML, et al. [Eye tracking disorders in schizophrenic patients and their parents]. Encephale. 2001;27(6):551-558.
32. Chen Y, Nakayama K, Levy DL, Matthysse S, Holzman PS. Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit. Proc Natl Acad Sci USA. 1999;96(8):4724-4729.
33. Clementz BA, Grove WM, Iacono WG, Sweeney JA, Katsanis J. Smooth-pursuit eye movement dysfunction and liability for schizophrenia: implications for genetic modeling. J Abnorm Psychol. 1992;101:117-129.
34. Grove WM, Clementz BA, Iacono WG, Katsanis J. Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene. Am J Psychiatry. 1992;149(10):1362-1368.
35. Ettinger U, Kumari V, Crawford TJ, et al. Smooth pursuit and antisaccade eye movements in siblings discordant for schizophrenia. J Psychiatr Res. 2004;38(2):177-184.
36. Holzman PS, Solomon CM, Levin S, Waternaux CS. Pursuit eye movement dysfunctions in schizophrenia. Family evidence for specificity. Arch Gen Psychiatry. 1984;41(2):136-139.
37. Holzman PS, Kringlen E, Matthysse S, et al. A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry. 1988;45(7):641-647.
38. Hong LE, Turano KA, O'neill H, et al. Refining the predictive pursuit endophenotype in schizophrenia. Biol Psychiatry. 2008;63(5):458-464.
39. Hong LE, Mitchell BD, Avila M, et al. Familial aggregation of eye tracking endophenotypes in families of schizophrenic patients. Arch Gen Psychiatry. 2006;63:1-6.
40. Karoumi B, Saoud M, d'Amato T, et al. Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia. Psychiatry Res. 2001;101(3):209-219.
41. Kathmann N, Hochrein A, Uwer R, Bondy B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry. 2003;160(4):696-702.
42. Lencer R, Malchow CP, Krecker K, et al. Smooth pursuit performance in families with multiple occurrence of schizophrenia and nonpsychotic families. Biol Psychiatry. 1999;45(6):694-703.
43. Litman RE, Torrey EF, Hommer DW, et al. A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia [see comments]. Arch Gen Psychiatry. 1997;54(5):417-426.
44. Rosenberg DR, Sweeney JA, Squires-Wheeler E, et al. Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry Res. 1997;66(2-3):121-130.
45. Ross RG. Early expression of a pathophysiological feature of schizophrenia: saccadic intrusions into smooth-pursuit eye movements in school-age children vulnerable to schizophrenia. J Am Acad Child Adolesc Psychiatry. 2003;42(4):468-476.
46. Rybakowski JK, Borkowska A. Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients. Schizophr Res. 2002;54(1-2):105-110.
47. Thaker GK, Ross DE, Cassady SL, et al. Smooth pursuit eye movements to extraretinal motion signals: deficits in relatives of patients with schizophrenia. Arch Gen Psychiatry. 1998;55(9):830-836.
48. Thaker GK, Cassady S, Adami H, Moran M, Ross DE. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients. Am J Psychiatry. 1996;153(3):362-368.
49. Ross RG, Olincy A, Harris JG, Sullivan B, Radant A. Smooth pursuit eye movements in schizophrenia and attentional dysfunction: adults with schizophrenia, ADHD, and a normal comparison group. Biol Psychiatry. 2000;48:197-203.
50. Whicker L, Abel LA, Dell'Osso LF. Smooth pursuit eye movements in the parents of schizophrenics. Neuro-ophthalmology. 1985;5:1-8.
51. Hong LE, Avila M, Adami H, Elliott A, Thaker GK. Components of the smooth pursuit function in deficit and nondeficit schizophrenia. Schizophr Res. 2003;63(1-2):39-48.
52. Tadin D, Kim J, Doop ML, et al. Weakened center-surround interactions in visual motion processing in schizophrenia. J Neurosci. 2006;26(44):11403-11412.
53. Thaker GK, Avila MT, Hong E, et al. A model of smooth pursuit eye movement deficit associated with the schizophrenia phenotype. Psychophysiology. 2003;40:277-284.
54. Frith CD. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med. 1987;17(3):631-648.
55. Heinks-Maldonado TH, Mathalon DH, Houde JF, et al. Relationship of imprecise corollary discharge in schizophrenia to auditory hallucinations. Arch Gen Psychiatry. 2007;64(3):286-296.
56. Sweeney JA, Luna B, Haas GL, et al. Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients. Biol Psychiatry. 1999;46(5):671-680.
57. Friedman L, Jesberger JA, Siever LJ, et al. Smooth pursuit performance in patients with affective disorders or schizophrenia and normal controls: analysis with specific oculomotor measures, RMS error and qualitative ratings. Psychol Med. 1995;25(2):387-403.
58. Levy DL, Yasillo NJ, Dorus E, et al. Relatives of unipolar and bipolar patients have normal pursuit. Psychiatry Res. 1983;10(4):285-293.
59. Wilmer JB, Richardson AJ, Chen Y, Stein JF. Two visual motion processing deficits in developmental dyslexia associated with different reading skills deficits. J Cogn Neurosci. 2004;16(4):528-540.
60. Matthysse S, Holzman PS, Gusella JF, et al. Linkage of eye movement dysfunction to chromosome 6p in schizophrenia: additional evidence. Am J Med Genet. 2004;128B(1):30-36.
61. Harold D, Paracchini S, Scerri T, et al. Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry. 2006;11(12):1085-1091.
62. Thaker GK, Wonodi I, Avila MT, Hong LE, Stine OC. Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report. Am J Psychiatry. 2004;161(12):2320-2322.
63. Wonodi I, Hong LE, Mitchell BD, et al. Effect of dopamine transporter (DAT1) WNTR polymorphism on eye tracking endophenotypes in schizophrenia. Neuropsychopharmacology. 2006;31:suppl 1S174.
64. Oswald LM, McCaul M, Choi L, Yang X, Wand GS. Catechol-O- methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report. Biol Psychiatry. 2004;55(1):102-105.
65. Freedman R, Adler LE, Leonard S. Alternative phenotypes for the complex genetics of schizophrenia. Biol Psychiatry. 1999;45(5):551-558.
66. Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir JM. Diabetes and development of tardive dyskinesia. Am J Psychiatry. 1993;150(6):966-968.
67. Adler LE, Olincy A, Cawthra EM, et al. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry. 2004;161(10):1822-1828.
68. Arango C, Summerfelt A, Buchanan RW. Olanzapine effects on auditory sensory gating in schizophrenia. Am J Psychiatry. 2003;160(11):2066-2068.
69. de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Linszen DH. A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophr Res. 2007;97(1-3):137-151.
70. Franks RD, Adler LE, Waldo MC, Alpert J, Freedman R. Neurophysiological studies of sensory gating in mania: comparison with schizophrenia. Biol Psychiatry. 1983;18(9):989-1005.
71. Baker NJ, Staunton M, Adler LE, et al. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatry. 1990;27(5):519-528.
72. Sanchez-Morla EM, Garcia-Jimenez MA, Barabash A, et al. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand. 2008;117(4):313-318.
73. Hall MH, Schulze K, Sham P, et al. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: a combined twin and family study. Am J Med Genet B Neuropsychiatr Genet. 2008.
74. Schulze KK, Hall MH, McDonald C, et al. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry. 2007;62(2):121-128.
75. Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res. 2004;126(3):203-215.
76. Traub RD, Jefferys JG, Whittington MA. Fast oscillations in cortical circuits. Cambridge, MA: The MIT Press; 1999.
77. Traub RD, Whittington MA, Buhl EH, Jefferys JG, Faulkner HJ. On the mechanism of the gamma/beta frequency shift in neuronal oscillations induced in rat hippocampal slices by tetanic stimulation. J Neurosci. 1999;19(3):1088-1105.
78. Kopell N, Ermentrout GB, Whittington MA, Traub RD. Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci USA. 2000;97(4):1867-1872.
79. Bibbig A, Faulkner HJ, Whittington MA, Traub RD. Self-organized synaptic plasticity contributes to the shaping of gamma and beta oscillations in vitro. J Neurosci. 2001;21(22):9053-9067.
80. Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. NeuroReport. 1997;8(18):3889-3893.
81. Haenschel C, Baldeweg T, Croft RJ, Whittington M, Gruzelier J. Gamma and beta frequency oscillations in response to novel auditory stimuli: a comparison of human electroencephalogram (EEG) data with in vitro models. Proc Natl Acad Sci USA. 2000;97(13):7645-7650.
82. Hong LE, Summerfelt A, McMahon RP, Thaker GK, Buchanan RW. Gamma/beta oscillation and sensory gating deficit in schizophrenia. NeuroReport. 2004;15:155-159.
83. Hong LE, Mitchell BD, Avila MT, McMahon RP, Adami HM, Thaker GK. Familial aggregation of eye tracking endophenotypes in schizophrenia familes. Schizophr Bull. 2005;31:471.
84. Hong LE, Buchanan RW, Thaker GK, Shepard PD, Summerfelt A. Beta (approximately 16 Hz) frequency neural oscillations mediate auditory sensory gating in humans. Psychophysiology. 2008;45(3):197-204.
85. Engel AK, Fries P, Singer W. Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci. 2001;2(10):704-716.
86. Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci. 2005;9(10):474-480.
87. Fries P, Nikolic D, Singer W. The gamma cycle. Trends Neurosci. 2007;30(7):309-316.
88. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 1992;587(1):130-136.
89. Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha-7 nicotine acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002;12:1085-1096.
90. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 1992;32(7):607-616.
91. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150(12):1856-1861.
92. Adler LE, Hoffer L, Nagamoto HT, et al. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 1994;10(4):249-257.
93. Adler LE, Waldo MC, Tatcher A, et al. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophr Res. 1990;3(2):131-138.
94. Potter D, Summerfelt A, Gold J, Buchanan RW. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull. 2006;32(4):692-700.
95. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 1997;94(2):587-592.
96. Martin LF, Leonard S, Hall MH, et al. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet. 2007;144(5):611-614.
97. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001;156(2-3):234-258.
98. GrahamPresidential Address FK. The more or less startling effects of weak prestimulation. Psychophysiology. 1974;12(3):238-2481975.
99. Greenwood TA, Braff DL, Light GA, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007;64(11):1242-1250.
100. Perry W, Minassian A, Feifel D, Braff DL. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001;50(6):418-424.
101. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley bipolar disorder project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry. 2005;58(11):859-864.
102. Martinez-Aran A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224-232.
103. Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93(1-3):105-115.
104. Barrett SL, Kelly C, Watson DR, Bell R, King DJ. Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder. Psychol Med. 2005;35(12):1737-1746.
105. Rich BA, Vinton D, Grillon C, Bhangoo RK, Leibenluft E. An investigation of prepulse inhibition in pediatric bipolar disorder. Bipolar Disord. 2005;7(2):198-203.
106. Cannon DM, Ichise M, Fromm SJ, et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry. 2006;60(3):207-217.
107. Giakoumaki SG, Roussos P, Rogdaki M, et al. Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar disorder patients. Biol Psychiatry. 2007;62(12):1418-1422.
108. Kumari V, Gray JA, ffytche DH, et al. Cognitive effects of nicotine in humans: an fMRI study. NeuroImage. 2003;19(3):1002-1013.
109. Kumari V, Das M, Zachariah E, Ettinger U, Sharma T. Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology. 2005;42(5):588-594.
110. Mann C, Croft RJ, Scholes KE, et al. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensorimotor and sensory gating in humans. Neuropsychopharmacology. 2007.
111. Abel KM, Allin MP, Hemsley DR, Geyer MA. Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology. 2003;44(6):729-737.
112. Oranje B, Gispen-de Wied CC, Verbaten MN, Kahn RS. Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol. Biol Psychiatry. 2002;52(9):887-895.
113. van Berckel BN, Oranje B, van Ree JM, Verbaten MN, Kahn RS. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl). 1998;137(3):271-281.
114. Duncan EJ, Madonick SH, Parwani A, et al. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology. 2001;25(1):72-83.
115. Hong LE, Wonodi I, Lewis J, Thaker GK. Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology. Advance online publication October 24, 2007, doi:101038/sj.npp.1301601.
116. George TP, Termine A, Sacco KA, et al. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res. 2006;87(1-3):307-315.
117. Kumari V, Soni W, Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol. 2001;16(4):321-326.
118. Braff D, Stone C, Callaway E, et al. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978;15(4):339-343.
119. Cadenhead KS, Geyer MA, Braff DL. Impaired startle pre-pulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 1993;150(12):1862-1867.
120. van den BM, Martin S, Holgate J, Matthaei K, Hendry I. Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background. Psychopharmacology (Berl). 2007;195(2):273-283.
121. Petryshen TL, Kirby A, Hammer RP, Jr, et al. Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains. Genetics. 2005;171(4):1895-1904.
122. Hong LE, Wonodi I, Stine OC, Mitchell BD, Thaker GK. Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry. 2008;63(1):17-23.
123. Doherty JM, Masten VL, Powell SB, et al. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology. Advance online publication December 12, 2007, doi:101038/sj.npp.1301657.
124. Roussos P, Giakoumaki SG, Rogdaki M, et al. Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism. Psychol Med. Advance online publication February 8, 2008, doi:10.1017/S0033291708002912.
125. Roussos P, Giakoumaki SG, Bitsios P. The dopamine D3 receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex. Biol Psychiatry. Advance online publication March 6, 2008, doi:10.1016/j.biopsych.2008.01.020.
126. Wonodi I, Hong LE, Stine OC, Lewis J, Lin PI, Thaker GK. Effect of dopamine transporter VNTR polymorphism on prepulse inhibition in schizophrenia. Biol Psychiatry. 2008;63(7S):273S.
127. Bledowski C, Prvulovic D, Hoechstetter K, et al. Localizing P300 generators in visual target and distractor processing: a combined event-related potential and functional magnetic resonance imaging study. J Neurosci. 2004;24(42):9353-9360.
128. Salisbury DF, Griggs CB, Shenton ME, McCarley RW. The NoGo P300 'anteriorization' effect and response inhibition. Clin Neurophysiol. 2004;115(7):1550-1558.
129. Squires KC, Wickens C, Squires NK, Donchin E. The effect of stimulus sequence on the waveform of the cortical event-related potential. Science. 1976;193(4258):1142-1146.
130. van der SO, Lieberman JA, Belger A. Auditory P300 in high-risk, recent-onset and chronic schizophrenia. Schizophr Res. 2005;77(2-3):309-320.
131. Salisbury DF, Voglmaier MM, Seidman LJ, McCarley RW. Topographic abnormalities of P3 in schizotypical personality disorder. Biol Psychiatry. 1996;40:165-172.
132. Saitoh O, Hiwa S, Hiramasatu K, et al. Abnormalities in late positive components of event-related potentials may reflect a genetic predisposition to schizophrenia. Biol Psychiatry. 1984;19:293-303.
133. Condray R, Steinhauer SR, van Kammen DP, Zubin J. Dissociation of neurocognitive deficits in a monozygotic twin pair concordant for schizophrenia. J Neuropsychiatry Clin Neurosci. 1992;4(4):449-453.
134. Blackwood DH, St Clair DM, Muir WJ, Duffy JC. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry. 1991;48(10):899-909.
135. O'Connor S, Morzorati S, Christian JC, Li TK. Heritable features of the auditory oddball event-related potential: peaks, latencies, morphology and topography. Electroencephalogr Clin Neurophysiol. 1994;92(2):115-125.
136. Polich J, Burns T. P300 from identical twins. Neuropsychologia. 1987;25(1B):299-304.
137. Wright MJ, Hansell NK, Geffen GM, et al. Genetic influence on the variance in P3 amplitude and latency. Behav Genet. 2001;31(6):555-565.
138. van Beijsterveldt CE, van Baal GC, Molenaar PC, Boomsma DI, de Geus EJ. Stability of genetic and environmental influences on P300 amplitude: a longitudinal study in adolescent twins. Behav Genet. 2001;31(6):533-543.
139. Hall MH, Rijsdijk F, Kalidindi S, et al. Genetic overlap between bipolar illness and event-related potentials. Psychol Med. 2007;37(5):667-678.
140. O'Donnell BF, Vohs JL, Hetrick WP, Carroll CA, Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. Int J Psychophysiol. 2004;53(1):45-55.
141. Salisbury DF, Shenton ME, McCarley RW. P300 topography differs in schizophrenia and manic psychosis. Biol Psychiatry. 1999;45(1):98-106.
142. Schulze KK, Hall MH, McDonald C, et al. Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord. 2008;10(3):377-386.
143. Hill SY, Locke J, Zezza N, et al. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry. 1998;43(1):40-51.
144. Mulert C, Juckel G, Giegling I, et al. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology. 2006;31(6):1335-1344.
145. Gallinat J, Bajbouj M, Sander T, et al. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry. 2003;54(1):40-48.
146. Blackwood DH, Fordyce A, Walker MT, et al. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet. 2001;69(2):428-433.
147. Muir WJ, St Clair DM, Blackwood DH. Long-latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder. Psychol Med. 1991;21(4):867-879.
148. Pierson A, Jouvent R, Quintin P, Perez-Diaz F, Leboyer M. Information processing deficits in relatives of manic depressive patients. Psychol Med. 2000;30(3):545-555.
149. Maurage P, Philippot P, Verbanck P, et al. Is the P300 deficit in alcoholism associated with early visual impairments (P100, N170)? An oddball paradigm. Clin Neurophysiol. 2007;118(3):633-644.
150. Tervaniemi M, Maury S, Naatanen R. Neural representations of abstract stimulus features in the human brain as reflected by the mismatch negativity. NeuroReport. 1994;5(7):844-846.
151. Michie PT. What has MMN revealed about the auditory system in schizophrenia? Int J Psychophysiol. 2001;42(2):177-194.
152. Jessen F, Fries T, Kucharski C, et al. Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia. Neurosci Lett. 2001;309(3):185-188.
153. Michie PT, Innes-Brown H, Todd J, Jablensky AV. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders. Biol Psychiatry. 2002;52(7):749-758.
154. Umbricht D, Koller R, Schmid L, et al. How specific are deficits in mismatch negativity generation to schizophrenia? Biol Psychiatry. 2003;53(12):1120-1131.
155. Catts SV, Shelley AM, Ward PB, et al. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry. 1995;152(2):213-219.
156. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry. 2005;62(2):127-136.
157. Kwon JS, O'Donnell BF, Wallenstein GV, et al. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry. 1999;56(11):1001-1005.
158. Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA. 2006;103(52):19878-19883.
159. Uhlhaas PJ, Linden DE, Singer W, et al. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia. J Neurosci. 2006;26(31):8168-8175.
160. Lee KH, Williams LM, Haig A, Gordon E. "Gamma (40 Hz) phase synchronicity" and symptom dimensions in schizophrenia. Cognit Neuropsychiatry. 2003;8(1):57-71.
161. Hong LE, Summerfelt A, McMahon R, et al. Evoked gamma band synchronization and the liability for schizophrenia. Schizophr Res. 2004;70(2-3):293-302.
162. Spencer KM, Nestor PG, Perlmutter R, et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA. 2004;101(49):17288-17293.
163. O'Donnell BF, Hetrick WP, Vohs JL, et al. Neural synchronization deficits to auditory stimulation in bipolar disorder. NeuroReport. 2004;15(8):1369-1372.
164. Roopun AK, Middleton SJ, Cunningham MO, et al. A beta2-frequency (20-30 Hz) oscillation in nonsynaptic networks of somatosensory cortex. Proc Natl Acad Sci USA. 2006;103(42):15646-15650.
165. Vreugdenhil M, Bracci E, Jefferys JG. Layer-specific pyramidal cell oscillations evoked by tetanic stimulation in the rat hippocampal area CA1 in vitro and in vivo. J Physiol. 2005;562(Pt 1):149-164.
166. Sugai T, Onoda N. Effects of N-methyl-D-aspartate glutamate receptor antagonists on oscillatory signal propagation in the guinea-pig accessory olfactory bulb slice: characterization by optical, field potential and patch clamp recordings. Neuroscience. 2005;135(2):583-594.
167. Kantor AF, Greene MH, Boice JD, Fraumeni JF, Jr., Flannery JT. Are vinca alkaloids associated with myocardial infarction? Lancet. 1981;1(8229):1111.
168. Fujisawa S, Matsuki N, Ikegaya Y. Chronometric readout from a memory trace: gamma-frequency field stimulation recruits timed recurrent activity in the rat CA3 network. J Physiol. 2004;561(Pt 1):123-131.
169. Hajos M, Hurst RS, Hoffmann WE, et al. The selective alpha 7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]- 4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther. 2005;312(3):1213-1222.
170. Palhalmi J, Paulsen O, Freund TF, Hajos N. Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices. Neuropharmacology. 2004;47(3):381-389.